THIS IS AN ASPIRE PHARMA WEBSITE PAGE INTENDED FOR UK PATIENTS WHO HAVE BEEN PRESCRIBED LECICARBON A OR LECICARBON C (SODIUM HYDROGEN CARBONATE, SODIUM DIHYDROGEN PHOSPHATE)
Adverse event reporting can be found at the bottom of the page.
About Lecicarbon
Lecicarbon A Suppository is suitable for adults and children over 12 years of age.1
Lecicarbon C Suppository is suitable for children under 12 years of age.2
Mode of Action
Works within 15-30 minutes3
Unlike oral products that have to pass through the digestive system, Lecicarbon gets to work when you need it.
After insertion, the body’s temperature melts the suppository, which causes the two salts, sodium hydrogen carbonate and sodium dihydrogen phosphate, to react. The reaction releases carbon dioxide, which gently rises up the rectum causing peristalsis (the intestinal movement).
After 15-30 minutes the desired effect should occur, and you should experience relief from constipation.3
Therapeutic indications:
Short term treatment of constipation due to various causes (eg. nutrition poor in fibres, lack of physical activity, as well as diseases requiring easy defecation). 3
Emptying the colon before diagnostic or therapeutic procedures in the rectum. 3
Contraindications:
Lecicarbon should not be used:
- If you are allergic or hypersensitive to peanut or soya or to one of the excipients of Lecicarbon suppositories
- In cases of ileus or anal/rectal diseases leading to excessive CO2
- In the presence of toxic megacolon (pathological enlargement of the end of the large intestine due to various causes) the product should only be used with explicit permission of the treating physician.
Patient Information Leaflets
Clicking on these images will take you to the electronic Medicines Compendium (eMC) website to view the Patient Information Leaflet (PIL).
By clicking them, you will leave the Lecicarbon website and be re-directed to an external site: Aspire Pharma is not responsible for the content on external websites.
Summary of Product Characteristics
Clicking on these images will take you to the electronic Medicines Compendium (eMC) website to view the Summary of Product Characteristics (SmPC).
By clicking them, you will leave the Lecicarbon website and be re-directed to an external site: Aspire Pharma is not responsible for the content on external websites.
References:
1) Lecicarbon A Suppository Patient Information Leaflet (PIL).
2) Lecicarbon C Suppository Patient Information Leaflet (PIL).
3) Lecicarbon A & C Summary of Product Characteristics
4) NICE Clinical Knowledge Summary. Constipation (Accessed October 2025).
MAT-UK-LEC-0009-1 | October 2025
Reporting of Side Effects
If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes any possible side effects not listed in the product’s package leaflet.
You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard
By reporting side effects, you can help provide more information on the safety of medicines.
